已收盤 05-08 16:00:00 美东时间
+0.429
+1.69%
Merck (MRK) was up around 5% premarket on Thursday after it beat top- and bottom-line estimates for Q1 and issued a narrowed outlook for 2026. The Rahway, New Jersey–based company adjusted its guidanc...
04-30 18:59
https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026
04-21 23:50